PTGX EBITDA
Protagonist Therapeutics Inc · EBITDA
PTGX EBITDA
Latest reported$85.88Mperiod ending
PTGX EBITDA (-$9.06M → $85.88M)
Annual EBITDA
High-resolution chart · PNG
PTGX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -128,031,000 | |
| 282,371,000 | |
| -75,643,000 | |
| -124,024,000 | |
| -122,776,000 | |
| -61,793,000 | |
| -75,185,000 | |
| -39,196,000 | |
| -36,551,000 | |
| -32,349,000 | |
| -14,547,000 | |
| -9,061,000 |